Novel Opportunities for CFTR-targeting Drug Development Using Organoids

Rare Diseases
doi 10.4161/rdis.27112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Mitochondrial Targeting for Drug Development

2015English

CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2019English

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

Polymers
PolymersPlasticsChemistry
2020English

Dendrimers: A Novel Tool for Drug Delivery and Targeting

Universal Journal of Pharmaceutical Research
2017English

FDA Critical Path Initiatives: Opportunities for Generic Drug Development

AAPS Journal
Pharmaceutical Science
2008English

Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery

Frontiers in Pharmacology
Pharmacology
2020English

Targeting FtsZ for Antituberculosis Drug Discovery: Noncytotoxic Taxanes as Novel Antituberculosis Agents

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2006English

Orphan Drug Development in China ‒ Turning Challenges Into Opportunities

Intractable and Rare Diseases Research
Medicine
2016English

Decades of Research in Drug Targeting Using Gastroretentive Drug Delivery Systems for Antihypertensive Therapy

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy